You know what struck me? It's that the very important work of the subcommittee has brought awareness and is bringing some very good dialogue. It's great to see the different countries doing different studies. Because this is a collaborative medical community or a scientific community, we can actually get the answers that we want rather than the political debates about it.
I think that's what's so important, and I think that's what this committee wants. There are very good questions this morning.
With that, I'm going to suspend for two minutes, and then we'll go into our next segment, which is with the Alzheimer Society.